Connect Biopharma Holdings LTD (CNTB) — SC 13D/A Filings

All SC 13D/A filings from Connect Biopharma Holdings LTD. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (3)

Connect Biopharma Ownership Update — Jul 1, 2024 Risk: medium
On July 1, 2024, James Huang and Panacea Venture Healthcare Fund II, L.P. filed an amendment (No. 2) to their Schedule 13D regarding Connect Biopharma Holdings
Panacea Venture Group Amends Connect Biopharma 13D Filing — Feb 27, 2024 Risk: medium
Panacea Innovation Ltd, along with group members James Huang, Panacea Venture Healthcare Fund II GP Co Ltd., and Panacea Venture Healthcare Fund II L.P., filed
RA Capital Amends Connect Biopharma Stake (Amendment No. 5) — Feb 27, 2024 Risk: medium
RA Capital Management, L.P. filed an SC 13D/A Amendment No. 5 on February 27, 2024, regarding its beneficial ownership in Connect Biopharma Holdings Ltd. The fi

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX